![]() The American College of Radiology, ACR, has released 2018 new and revised practice parameters and technical standards covering 27 radiology topics, including ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET-CT for Neuroendocrine Tumors:.The NCCN guidelines are available at no charge here. “The intent of the NCCN Guidelines is to assist in the decision-making process of individuals involved in cancer care-including physicians, nurses, pharmacists, payers, patients and their families-with the ultimate goal of advancing patient care in the fight against cancer.” CLICK HERE to read the press release. Gallium 68 DOTATATE PET/CT imaging using NETSPOT® has been included in the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology version 1.2017 update for the evaluation of neuroendocrine tumors.Gallium 68 is here, what does that mean? Blog article by neuroendocrine tumor expert Eric Liu, MD.FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors,.įor your information, here are some articles about Gallium-68 imaging: To read the Advanced Accelerator Applications press release about the Transitional Pass-Through Status, click here. ![]() While it does not guarantee that individual patients will get insurance coverage, this is a very positive step for getting more institutions to offer the Gallium-68 scan. What this means is that the different institutions doing the Gallium-68 scan utilizing NETSPOT® now have a reimbursement code to submit to Medicare/Medicaid and private payors. The Centers for Medicare & Medicaid Services (CMS) granted NETSPOT® Transitional Pass-Through Status under an “A-code” (A9587) for drug reimbursement, effective January 1, 2017. ![]() Check with your insurance company to determine if the scan will be covered.Obtain a referral (if needed) to the institution offering the scan.Discuss this imaging test with your physician.If you know of other institutions that offer the scan, please contact the Carcinoid Cancer Foundation by phone at 88, Eastern Time, or by email at and share the name of the institution, city, state, and phone number for more information about the scan.īefore scheduling a Gallium-68 scan you should: We will be adding to the list on a monthly basis based on feedback from the NET community. For further information, please contact the PET/CT department or the Nuclear Medicine department at the institution. Most of these in the United States will be the scan using NETSPOT® others will be scans that are in clinical trial. Locations of the Gallium-68 PET/CT scan have been submitted, in part, in response to a post on the Carcinoid Cancer Foundation’s Facebook page inquiring where people have had the scan around the world. ![]() PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST OF WHERE THE SCAN IS OFFERED The US Food and Drug Administration’s (FDA) Japproval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States. Medical Opinion: When to Start and How to Treat Metastatic Carcinoid.Medical Opinion: Diagnosis and Treatment.Resources for Carcinoid and NET Cancer Insurance Appeals.Nutrition and Diet for Carcinoid Patients.Nutritional Concerns For The Carcinoid Patient. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |